Single-Gene Disorders

Some diseases can be traced to a single misspelled instruction in the three-billion-letter book of the human genome. Change one base pair in one gene, and a child may be born with lungs that clog with thick mucus, or red cells that collapse into sickles and jam the smallest blood vessels. These are the single-gene, or Mendelian, disorders — conditions that obey the same inheritance rules Gregor Mendel worked out in a monastery garden with pea plants. They are individually rare but collectively affect roughly 1 in 100 births, and understanding them is the foundation on which the whole discipline of medical genetics rests.

This page teaches you how single-gene disorders are inherited, how a single mutation produces disease at the molecular level, and how two of the classic conditions — cystic fibrosis and sickle cell disease — illustrate the general principles. Sickle cell disease holds a special place in medical history: in 1949 it became the first illness ever shown to have a defined molecular cause, launching the era of molecular medicine.

Learning Objectives

• Define a single-gene (Mendelian) disorder and distinguish it from chromosomal and multifactorial disease.
• Recognise the four classic inheritance patterns and their pedigree signatures: autosomal dominant, autosomal recessive, X-linked recessive, X-linked dominant.
• Explain the molecular pathology of sickle cell disease and cystic fibrosis from mutation to clinical phenotype.
• Describe why sickle cell disease is called "the first molecular disease" and what Pauling and Ingram actually showed.
• Apply concepts of penetrance, expressivity, carrier frequency, and heterozygote advantage to clinical scenarios.
• Calculate recurrence risks for common Mendelian crosses and counsel families appropriately.

Quick Answer

A single-gene disorder is a disease caused by a mutation in one gene, inherited in a predictable Mendelian pattern. Autosomal dominant conditions manifest with one mutant allele and appear in every generation; autosomal recessive conditions (like cystic fibrosis and sickle cell disease) require two mutant alleles and typically arise from unaffected carrier parents; X-linked recessive conditions mainly affect males. Cystic fibrosis results from mutations in the CFTR chloride channel — most commonly the F508del deletion — producing thick secretions in the lungs, pancreas, and other organs. Sickle cell disease results from a single amino-acid substitution (glutamate to valine) at position 6 of the beta-globin chain, causing haemoglobin to polymerise when deoxygenated. Sickle cell was the first disease traced to a specific molecular defect, by Linus Pauling in 1949 and Vernon Ingram in 1956.

Where It Came From

The intellectual roots run back to Gregor Mendel (1865), whose pea-plant experiments established that traits are passed on as discrete units — what we now call genes — in dominant and recessive forms. Mendel's work was ignored for 35 years, then rediscovered around 1900. In 1902 the physician Archibald Garrod, studying alkaptonuria (a condition where urine turns black on standing), proposed that it was inherited as a Mendelian recessive and reflected a blocked chemical step — his phrase "inborn errors of metabolism" was the first time human disease was framed as a genetic biochemical defect. He was decades ahead of his time.

The true turning point came with sickle cell disease. The disease had been described clinically in 1910 by James Herrick, who noted "peculiar elongated and sickle-shaped" red cells in an anaemic dental student. But the cause was a mystery for forty years. Then in 1949, Linus Pauling and colleagues used electrophoresis to show that haemoglobin from sickle cell patients moved differently in an electric field than normal haemoglobin — the molecule itself was physically abnormal. Pauling coined the term "molecular disease," and this was the first time any illness had been pinned to a specific altered protein. The same year, J.B.S. Haldane and colleagues suggested that carriers might be protected against malaria, explaining why such a "harmful" gene stayed common.

The picture was completed in 1956 by Vernon Ingram, who used protein fingerprinting to show that the entire difference between normal and sickle haemoglobin was a single amino acid — one glutamate replaced by one valine. A single letter in the genetic code, causing a lethal disease. This was breathtaking proof that the emerging DNA-to-protein logic of molecular biology applied directly to human medicine. The need driving all of this was simple but profound: physicians wanted to know why families passed on disease, and whether they could predict, prevent, or one day correct it.

Inheritance Patterns: The Four Classic Modes

Every Mendelian disorder follows one of a small number of patterns, dictated by whether the gene is on an autosome or a sex chromosome and whether the mutant allele is dominant or recessive.

Autosomal recessive (AR). Two mutant copies are needed. Parents are usually healthy carriers (heterozygotes). Each child of two carriers has a 1 in 4 (25%) chance of being affected, a 1 in 2 chance of being a carrier, and a 1 in 4 chance of being unaffected non-carrier. Disease often appears with no prior family history and is more common when parents are related (consanguinity). Cystic fibrosis and sickle cell disease are both AR, as are Tay-Sachs disease, phenylketonuria, and most inborn errors of metabolism.

Autosomal dominant (AD). One mutant copy is enough to cause disease. The condition appears in every generation, affected individuals have (on average) half their children affected, and males and females are equally affected with male-to-male transmission possible. Examples: Huntington disease, Marfan syndrome, familial hypercholesterolaemia, achondroplasia, neurofibromatosis type 1.

X-linked recessive (XLR). The gene is on the X chromosome. Males (XY) are affected if they inherit one mutant allele because they have no second X to compensate; females (XX) are usually carriers. Classic signature: affected males, no male-to-male transmission, carrier mothers. Examples: Duchenne muscular dystrophy, haemophilia A and B, red-green colour blindness, G6PD deficiency.

X-linked dominant (XLD). Rare. Affected females (often milder, being heterozygous) outnumber males; affected fathers pass it to all daughters and no sons. Some conditions are lethal in males (e.g. Rett syndrome, incontinentia pigmenti).

Worked example: a cystic fibrosis cross

Two healthy parents each carry one CFTR mutation (genotype Aa, where "a" is the mutant allele). Their possible children: AA (unaffected, 25%), Aa (carrier, 50%), aa (affected, 25%). So each pregnancy carries a 25% risk of an affected child — and this risk is the same for every pregnancy, regardless of previous children. A common counselling error is to think that after one affected child the "1 in 4 is used up." It is not; chance has no memory.

Cystic Fibrosis: One Channel, Many Organs

Cystic fibrosis (CF) is the most common life-limiting autosomal recessive disorder in people of Northern European descent, with a carrier frequency of about 1 in 25 and an incidence around 1 in 2,500 births in that population. It is caused by mutations in the CFTR gene on chromosome 7, which encodes the cystic fibrosis transmembrane conductance regulator — a chloride channel sitting in the apical membrane of epithelial cells.

When CFTR fails, chloride (and with it water) cannot move properly across epithelial surfaces. Secretions become thick and sticky. The consequences ripple across multiple organ systems:

• Lungs: Viscous mucus clogs airways, impairs ciliary clearance, and creates a haven for chronic infection — classically Pseudomonas aeruginosa and Staphylococcus aureus. Repeated infection and inflammation cause bronchiectasis and progressive respiratory failure, still the main cause of death.
• Pancreas: Blocked ducts cause pancreatic enzymes to be trapped, leading to exocrine insufficiency, malabsorption, steatorrhoea (fatty stools), and failure to thrive. Over time, islet damage causes CF-related diabetes.
• Intestine: Newborns may present with meconium ileus — thick meconium obstructing the bowel.
• Sweat glands: Chloride cannot be reabsorbed, so sweat is abnormally salty. This is the basis of the diagnostic sweat chloride test (a value above 60 mmol/L is diagnostic).
• Reproductive tract: Most males with CF have congenital bilateral absence of the vas deferens, causing infertility.

The commonest mutation, F508del, is a three-base deletion removing a single phenylalanine at position 508. The resulting protein misfolds and is degraded before it ever reaches the cell surface (a "Class II" defect). Over 2,000 CFTR mutations are known, grouped into classes by mechanism — a distinction that now matters clinically because CFTR modulator drugs (such as ivacaftor, and the elexacaftor/tezacaftor/ivacaftor combination) are targeted to specific mutation classes and have transformed prognosis for many patients. This is precision medicine flowing directly from molecular understanding.

Sickle Cell Disease: The First Molecular Disease

Sickle cell disease (SCD) is caused by a single point mutation in the HBB gene (beta-globin, chromosome 11): an adenine-to-thymine change converts codon 6 from GAG to GTG, swapping the hydrophilic glutamate for hydrophobic valine. The resulting haemoglobin is called HbS.

The magic — and the tragedy — is in the biophysics. When HbS gives up its oxygen (in the tissues, or during infection, dehydration, cold, or high altitude), the exposed valine allows HbS molecules to stick together and polymerise into rigid fibres. These distort the red cell into the classic sickle shape. Sickled cells are inflexible and sticky; they:

• Occlude small blood vessels, causing painful vaso-occlusive crises, stroke, acute chest syndrome, splenic infarction, and eventually organ damage.
• Haemolyse (break down) prematurely, giving chronic anaemia, jaundice, gallstones, and a hyperdynamic circulation.

Homozygotes (HbSS) have the full disease. Heterozygotes (HbAS) have sickle cell trait — usually asymptomatic because normal HbA dilutes HbS enough to prevent polymerisation under ordinary conditions.

Heterozygote advantage and malaria

Why is a lethal gene so common — reaching carrier frequencies above 20% in parts of sub-Saharan Africa? Because HbAS carriers are relatively protected against falciparum malaria. Infected red cells sickle and are cleared, and the parasite grows poorly in HbS cells. This is a textbook example of balancing selection / heterozygote advantage: the mutant allele is maintained because carriers out-survive both homozygous groups in malarial regions. The global map of sickle cell frequency closely tracks the historical map of malaria — one of the most elegant demonstrations of natural selection in humans.

Modern management includes penicillin prophylaxis in children, pneumococcal vaccination, folate, hydration, prompt treatment of crises, and hydroxyurea, which raises protective fetal haemoglobin (HbF). Bone marrow transplant is curative in selected patients, and gene therapies are now reaching the clinic.

Real-World Applications

• Newborn screening: Both CF and SCD are detected by heel-prick screening in many countries, allowing early treatment that dramatically improves outcomes.
• Carrier and prenatal testing: Couples with a family history, or from high-risk populations, can be offered carrier screening; prenatal diagnosis (CVS, amniocentesis) and preimplantation genetic testing let families make informed choices.
• Precision therapeutics: CFTR modulators and sickle-cell gene therapy show how identifying the exact molecular defect leads directly to targeted cures rather than symptom management.
• Public health genetics: Understanding heterozygote advantage guides screening programmes in malaria-endemic and diaspora populations.
• Emergency care: Recognising a sickle cell crisis, or the salt loss and infection risk in CF, changes acute management at the bedside.

Common Mistakes

1. "After one affected child, the next is safe." Wrong. In autosomal recessive inheritance each pregnancy independently carries a 1 in 4 risk. Previous outcomes do not change the odds — chance has no memory.

2. Confusing sickle cell trait with sickle cell disease. Carriers (HbAS) are generally healthy and should not be told they have the disease. However they can rarely have problems under extreme hypoxia or dehydration, and the trait is relevant for genetic counselling. Labelling a carrier as "diseased" causes needless anxiety and stigma.

3. Assuming recessive means "no family history means no risk." Most children with AR disorders are born to carrier parents with no affected relatives, because carriers are silent. A clean family history does not exclude carrier status.

4. Thinking one mutation equals one predictable severity. Penetrance and expressivity vary. Different CFTR or modifier-gene combinations, and factors like HbF level in SCD, mean two people with the "same" disorder can differ greatly. Genotype guides, but does not fully dictate, phenotype.

Comparison and Connections

Feature	Cystic Fibrosis	Sickle Cell Disease
Inheritance	Autosomal recessive	Autosomal recessive
Gene / chromosome	CFTR / chr 7	HBB / chr 11
Mutation type	Commonly deletion (F508del)	Point mutation (Glu6Val)
Protein affected	Chloride channel	Beta-globin (haemoglobin)
Heterozygote	Silent carrier	Sickle trait; malaria protection
Key test	Sweat chloride	Haemoglobin electrophoresis
Highest frequency	Northern European	Sub-Saharan African ancestry

Related distinctions. Single-gene disorders differ from chromosomal disorders (whole extra or missing chromosomes, e.g. Down syndrome) and multifactorial disorders (many genes plus environment, e.g. type 2 diabetes). Within Mendelian disease, do not confuse dominant vs recessive (about the allele's effect) with penetrance (the proportion of people with the genotype who show the phenotype) or expressivity (how severely it shows).

Practice Questions

Recall

Q: What single amino-acid change causes sickle cell disease, and in which protein? A: Glutamate to valine at position 6 of the beta-globin chain (Glu6Val), caused by a GAG-to-GTG mutation in the HBB gene.

Understanding

Q: Why do most children with cystic fibrosis have unaffected parents? A: CF is autosomal recessive. Parents are typically heterozygous carriers who have one normal CFTR allele that produces enough functional channel, so they are healthy but each can pass the mutant allele on. Only a child inheriting two mutant alleles is affected.

Application

Q: A couple, both sickle cell carriers (HbAS), ask about risks for their next baby. What do you tell them? A: Each pregnancy has a 25% chance of an affected child (HbSS), a 50% chance of a carrier (HbAS), and a 25% chance of an unaffected non-carrier (HbAA). This applies to every pregnancy independently. Offer counselling and prenatal or preimplantation testing options.

Analysis

Q: Sickle cell trait is often called "harmful," yet the allele is common in some populations. Reconcile this. A: Balancing selection. In malaria-endemic regions HbAS carriers are protected against severe falciparum malaria, so they survive and reproduce better than both HbAA (susceptible to malaria) and HbSS (severe disease) individuals. This heterozygote advantage maintains the allele at high frequency despite the cost to homozygotes.

FAQ

Is being a carrier of cystic fibrosis or sickle cell something I would ever notice? Usually not. Carriers of these autosomal recessive conditions are healthy. Sickle cell carriers can very rarely have issues under extreme dehydration or oxygen deprivation, and can have blood in the urine, but day to day they are well.

If my partner and I are both carriers, is there any way to have an unaffected child? Yes. Options include prenatal diagnosis with the choice it allows, and preimplantation genetic testing, in which embryos created by IVF are tested and only unaffected ones implanted. Natural pregnancy still has a 75% chance of an unaffected child each time.

Can single-gene disorders be cured now? Increasingly, for some. CFTR modulator drugs treat the underlying defect in many CF mutations, and gene therapies for sickle cell disease have been approved. These are transformative but not yet universal or cheap.

Why is sickle cell called the "first molecular disease"? Because in 1949 Linus Pauling showed the haemoglobin molecule itself was physically abnormal in patients — the first time a disease was traced to a specific altered protein. Ingram later pinpointed the exact single amino-acid change.

Why is cystic fibrosis so much more common in some populations? Carrier frequency is high (about 1 in 25) in people of Northern European ancestry. One hypothesis is that carriers had some historical resistance to diarrhoeal diseases like cholera or typhoid, though this is less firmly established than the malaria link in sickle cell.

Quick Revision

• Single-gene (Mendelian) disorder = disease from a mutation in one gene, inherited predictably.
• Four patterns: AR, AD, XLR, XLD. AR needs two mutant alleles; carriers are healthy.
• CF: AR, CFTR chloride channel, chr 7, commonest mutation F508del; thick secretions in lungs, pancreas, gut; diagnosed by sweat chloride.
• SCD: AR, HBB beta-globin, chr 11; Glu6Val; HbS polymerises when deoxygenated causing vaso-occlusion and haemolysis.
• Sickle cell = first molecular disease (Pauling 1949; single amino acid shown by Ingram 1956).
• Carrier (HbAS) advantage against malaria explains high allele frequency (balancing selection).
• Two carriers: 25% affected, 50% carrier, 25% unaffected — every pregnancy, independently.

Related Topics

Prerequisites

• Medical Genetics overview
• Basic molecular biology: DNA, transcription, translation (see ../../3._Biochemistry/index.md)

Related Topics

• Haematology and haemoglobinopathies (../../31._Hematology/index.md)
• Inborn errors of metabolism and biochemical genetics
• Population genetics and natural selection

Next Topics

• Chromosomal disorders and multifactorial inheritance
• Genetic counselling and prenatal diagnosis
• Gene therapy and precision medicine